Sidebar Ads

Wednesday, February 6, 2019

Eli Lilly cuts 2019 forecast on trial failure, Loxo deal

Eli Lilly and Co cut its 2019 profit forecast on Wednesday, hit by a recent trial failure of conditionally approved cancer treatment Lartruvo and costs related to its pending acquisition of Loxo Oncology.


from Reuters: Business News https://reut.rs/2GsgygR

0 comments:

Post a Comment

Why are UK borrowing costs rising and what does it mean for me?

Government borrowing costs have hit their highest level for several years - what does it mean for you? from BBC News https://ift.tt/CsMhmd...